| Avatrombopag Usage in NSAA (NCT04728789) | Peking Union Medical College Hospital | 2021-02-01 |
| Valacyclovir for Mild Cognitive Impairment (NCT04710030) | New York State Psychiatric Institute | 2021-02-01 |
| The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients (NCT04751071) | Sadat City University | 2021-02-01 |
| Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT (NCT04746209) | Medical College of Wisconsin | 2021-02-01 |
| First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm Trial (NCT05574998) | Qianfoshan Hospital | 2021-02-01 |
| Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury (NCT04379011) | University of Minnesota | 2021-02-01 |
| A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) (NCT04701658) | Eli Lilly and Company | 2021-02-01 |
| Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2 (NCT04626089) | Laboratorios Silanes S.A. de C.V. | 2021-02-01 |
| The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients (NCT04757571) | Sadat City University | 2021-02-01 |
| GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC (NCT05023109) | Shanghai Zhongshan Hospital | 2021-02-01 |
| A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea (NCT04546828) | Samsung Medical Center | 2021-02-01 |
| Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer (NCT05267288) | Qingdao Central Hospital | 2021-02-01 |
| Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer (NCT04745975) | Fudan University | 2021-02-01 |
| A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety (NCT04286594) | Mclean Hospital | 2021-02-01 |
| A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection (NCT04667104) | Janssen Research & Development, LLC | 2021-02-01 |
| Neuroinflammation and Modulating Factors in Depression and HIV (NCT04286282) | University of Minnesota | 2021-02-01 |
| Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia (NCT04709731) | Associazione Italiana Pazienti Leucemia Mieloide Cronica | 2021-02-01 |
| Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC (NCT04653480) | Zhejiang University | 2021-02-01 |
| A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19 (NCT04770467) | Brii Biosciences, Inc. | 2021-02-01 |
| Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers (NCT04849559) | Vanda Pharmaceuticals | 2021-02-01 |
| Role of BP1.3656 on Alcohol Responses (NCT04727086) | Centre for Addiction and Mental Health | 2021-02-01 |
| Crossover Study of Propranolol vs Ivabradine in POTS (NCT04186286) | University of Calgary | 2021-02-01 |
| Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma (NCT04149275) | University of Alabama at Birmingham | 2021-02-01 |
| An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy (NCT04739046) | Seoul National University Bundang Hospital | 2021-02-01 |
| AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma (NCT04607200) | Agenus Inc. | 2021-02-01 |
| Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19 (NCT05226546) | Centre Hospitalier Universitaire Saint Pierre | 2021-02-01 |
| The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma (NCT04762745) | Sun Yat-sen University | 2021-02-01 |
| Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) (NCT04268706) | Tessa Therapeutics | 2021-02-01 |
| A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine (NCT04683224) | Vaxxinity, Inc. | 2021-02-01 |
| Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients (NCT05638893) | Tanta University | 2021-02-01 |
| A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (NCT04634552) | Janssen Research & Development, LLC | 2021-02-01 |
| Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis (NCT04685031) | Komar University of Science and Technology | 2021-02-01 |
| Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC (NCT05143099) | Shanghai Zhongshan Hospital | 2021-02-01 |
| PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer (NCT04700332) | Hoag Memorial Hospital Presbyterian | 2021-02-01 |
| Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas (NCT04701307) | M.D. Anderson Cancer Center | 2021-02-01 |
| Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor (NCT04667793) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-01-31 |
| Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL (NCT04740203) | Zhejiang University | 2021-01-31 |
| Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury (NCT04460872) | North Florida Foundation for Research and Education | 2021-01-31 |
| Zanubrutinib-based Induction and Maintenance Therapy in Young and Fit Patients With Untreated Mantle Cell Lymphoma (NCT04736914) | Sun Yat-sen University | 2021-01-31 |
| Tariquidar-ondansetron Combination in Neuropathic Pain (NCT04603066) | Washington University School of Medicine | 2021-01-31 |
| LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients (NCT04261387) | Lutris Pharma Ltd. | 2021-01-30 |
| Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19 (NCT05226767) | Todos Medical, Ltd. | 2021-01-30 |
| Evaluation of the Effect of Different Doses Dexmedetomidine Infusion on Lung Mechanics and Oxygenation in Obese Patients (NCT04730375) | National Cancer Institute, Egypt | 2021-01-30 |
| A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers (NCT04773067) | United Biomedical Inc., Asia | 2021-01-30 |
| Haplo-identical Transplantation in Patients With Myelofibrosis - A Phase 2 Prospective Multicentric Prospective Study (NCT04728490) | Assistance Publique - Hôpitaux de Paris | 2021-01-30 |
| Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy (NCT05001971) | Hunan Cancer Hospital | 2021-01-30 |
| Induced-T Cell Like NK Cells for B Cell Malignancies (NCT04747093) | Nanfang Hospital, Southern Medical University | 2021-01-29 |
| Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C (NCT04666298) | Novartis Pharmaceuticals | 2021-01-29 |
| Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC (NCT04543110) | Ottawa Hospital Research Institute | 2021-01-29 |
| Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD (NCT04446182) | University of Utah | 2021-01-29 |
| POLA+BR for Relapsed or Refractory DLBCL (NCT04535102) | University of Colorado, Denver | 2021-01-29 |
| Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb (NCT04614246) | Bayer | 2021-01-29 |
| A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity (NCT04707313) | Pfizer | 2021-01-29 |
| Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) (NCT04547140) | Grifols Therapeutics LLC | 2021-01-29 |
| Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction (NCT04049539) | Ohio State University Comprehensive Cancer Center | 2021-01-29 |
| Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer (NCT04285671) | Jonsson Comprehensive Cancer Center | 2021-01-29 |
| Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer (NCT04719273) | Thomas Jefferson University | 2021-01-28 |
| Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE) (NCT04515394) | EMD Serono Research & Development Institute, Inc. | 2021-01-28 |
| The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer (NCT04753177) | Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary | 2021-01-28 |
| Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome (NCT04604704) | AgelessRx | 2021-01-28 |
| 18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma (NCT04365660) | Davidzon, Guido, M.D. | 2021-01-28 |
| Intravenous Immunoglobulin and Prednisolone for RPL After ART. (NCT04701034) | Aalborg University Hospital | 2021-01-28 |
| Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) (NCT04676724) | GlaxoSmithKline | 2021-01-28 |
| Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea (NCT04530747) | Pennington Biomedical Research Center | 2021-01-28 |
| MR-HIFU Treatment of Painful Osteoid Osteoma (NCT04658771) | Children's National Research Institute | 2021-01-28 |
| CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma (NCT04727242) | Stanford University | 2021-01-28 |
| Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer (NCT04643366) | Virginia Commonwealth University | 2021-01-28 |
| Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer (NCT04776590) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-01-28 |
| A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) (NCT04700280) | Lakefront Biotherapeutics NV | 2021-01-28 |
| 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO) (NCT04667897) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2021-01-28 |
| A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT04632108) | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 2021-01-28 |
| An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib (NCT04485260) | Kartos Therapeutics, Inc. | 2021-01-28 |
| A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors (NCT04657068) | Artios Pharma Ltd | 2021-01-27 |
| A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma (NCT04728321) | Akeso | 2021-01-27 |
| "The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors" (NCT05355597) | Atlantic Health System | 2021-01-27 |
| Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy (NCT04554771) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-01-27 |
| Convalescent Plasma in the Treatment of Covid-19 (NCT04730401) | Helsinki University Central Hospital | 2021-01-27 |
| Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis (NCT04725136) | Kang Stem Biotech Co., Ltd. | 2021-01-27 |
| Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint. (NCT04609748) | Pomeranian Medical University Szczecin | 2021-01-27 |
| iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation (NCT03608631) | M.D. Anderson Cancer Center | 2021-01-27 |
| Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy (NCT04716946) | Memorial Sloan Kettering Cancer Center | 2021-01-27 |
| 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO) (NCT04667910) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2021-01-27 |
| Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab (NCT04536922) | National Cancer Institute (NCI) | 2021-01-27 |
| Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant (NCT04230356) | Children's Hospital Medical Center, Cincinnati | 2021-01-27 |
| Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma (NCT03868943) | Wake Forest University Health Sciences | 2021-01-27 |
| BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors (NCT04455620) | BioNTech SE | 2021-01-26 |
| Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma (NCT04720417) | Thomas Jefferson University | 2021-01-26 |
| Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma (NCT04701060) | Tianjin Medical University Cancer Institute and Hospital | 2021-01-26 |
| Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. (NCT04463771) | Incyte Corporation | 2021-01-26 |
| MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction) (NCT04050163) | Honya Medical Inc | 2021-01-26 |
| ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer (NCT04471974) | Rahul Aggarwal | 2021-01-26 |
| Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib (NCT04327700) | Wake Forest University Health Sciences | 2021-01-26 |
| Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease (NCT04595370) | AstraZeneca | 2021-01-26 |
| Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors (NCT04609566) | Seagen, a wholly owned subsidiary of Pfizer | 2021-01-26 |
| Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut (NCT05274438) | Peking University Cancer Hospital & Institute | 2021-01-26 |
| Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis (NCT04758650) | Universitair Ziekenhuis Brussel | 2021-01-26 |
| A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 (NCT04733833) | Vascular Biogenics Ltd. operating as VBL Therapeutics | 2021-01-26 |
| Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19 (NCT04498377) | EVIVE Biotechnology | 2021-01-26 |
| Impact of Colchicine and Low-dose Naltrexone on COVID-19 (NCT04756128) | HealthPartners Institute | 2021-01-25 |
| Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills" (NCT04676776) | Gynuity Health Projects | 2021-01-25 |